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HIV disclosure anxiety: A systematic review and theoretical synthesis 
Abstract 
HIV disclosure can help people living with HIV to access social support, enhance 
antiretroviral adherence, facilitate engagement in care and reduce unprotected sex. Given 
interpersonal risks associated with HIV disclosure, however, anxiety about sharing one’s 
status is common. To investigate anxiety about HIV disclosure in HIV-positive populations, 
we conducted a systematic review of qualitative and quantitative studies, with 119 studies 
included. The review demonstrated that perceived interpersonal risks are associated with HIV 
disclosure and outlined evidence of associations with anxiety, fear and worry. We present a 
new cognitive model of HIV disclosure anxiety adapted from clinical theories of health and 
social anxiety, consistent with evidence from the review. The model attempts to explain the 
development and maintenance of anxiety in individuals whose functioning is most affected by 
concerns about sharing their status. Implications for helping people living with HIV 
struggling with significant levels of anxiety about HIV disclosure are discussed.  
Key words: HIV disclosure; anxiety; fear; cognitive; model 
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Introduction 
HIV disclosure (sharing one’s HIV positive status with others) has a number of potentially 
positive consequences. HIV partner disclosure can reduce levels of unprotected sexual 
activity, partly through greater condom negotiation and use1-3, and facilitate partner HIV 
testing1. Sharing one’s status to partners or others can improve engagement in care1,4, and 
help in the initiation of and adherence to antiretroviral  treatment (ART) 5, through the 
availability of disclosure-specific support or the reduced need to hide medication from 
others6. There may also be psychological benefits to status sharing.  Well-being may be 
enhanced (although evidence is equivocal7) through increased social support8, the 
development of more helpful cognitive appraisal of HIV-related stressors and enhanced self-
esteem9,10. HIV disclosure may reduce anxiety levels, although again, evidence is 
equivocal1,7.  
Given the potential individual and public health benefits associated with HIV disclosure, the 
process of sharing one’s status with others could be thought of as a helpful health behaviour. 
HIV disclosure, however, exposes the person living with HIV (PLHIV) to potential rejection 
and discrimination. This is the case whether HIV disclosure is direct (the PLHIV telling 
others about their status), indirect (somebody else revealing the PLHIV’s status to others), or 
guessed (others concluding that the PLHIV is HIV-positive)11. In addition, once one’s status 
is shared with a particular individual, it cannot be unshared. Given the interpersonal risks 
associated with HIV disclosure, anxiety about sharing one’s status is likely to be the norm, 
generally serving to inhibit HIV disclosure. Concerns about other people knowing one’s HIV 
status may be heightened to the extent that very little or no HIV disclosure takes place. This 
can contribute to feelings of social isolation12. There may be some situations, however, when 
anxiety is influential in motivating disclosure rather than non-disclosure (e.g., when the 
PLHIV is concerned about others finding out about one’s status from a third party). 
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Some models of health behaviour recognise the importance of anxiety. The Self-Regulatory 
Model of Illness Behaviour 13 suggests that fear and anxiety (amongst other emotional and 
cognitive factors) influences coping with health threats. Fear is also included in the Protection 
Motivation Theory14 as a factor that influences behavioural intentions and health behaviour. 
To investigate the nature of anxiety about HIV disclosure in HIV-positive populations, we 
conducted a systematic review. As rates of HIV disclosure (and potentially the nature of HIV 
disclosure anxiety) differ according to context (e.g., the characteristics of the person living 
with HIV, the disclosure recipient, route of infection, whether disclosure is direct, indirect or 
guessed, and the time since diagnosis11,15,16),  our review adopted an inclusive approach to 
study eligibility.  
Method  
Study eligibility criteria 
Studies were included in the review if they: 
1. Were empirical, reporting primary data; 
2. Included HIV-positive participants; 
3. Reported or measured anxiety, worry or fear about HIV disclosure or one’s HIV 
status being shared;  
4. Referred to the PLHIV sharing their HIV status with others, others sharing the 
PLHIV’s status with third parties, or others guessing the PLHIV’s status; 
5. Assessed the association between anxiety/worry/fear about sharing one’s HIV status 
and any outcome, or cited disclosure anxiety/worry/fear as a reason for non-disclosure 
or any other outcome. 
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Sources of information and search strategy 
Studies published in peer-reviewed journals were retrieved from the electronic databases 
Pubmed/Medline and PsychINFO. There was no date restriction. The searches were 
conducted using combinations of the following terms: ‘anxiety’, ‘fear’, ‘worry’ and ‘HIV 
disclosure’ in either the title or abstract. The searches were conducted on 2nd January 2015.  
Data collection and abstraction 
The first author carried out the initial searches. All duplications were removed. The first 
author screened the remaining titles and abstracts for eligibility.  A random sample of 20% of 
the articles at this stage was independently rated by both the first author and a second 
reviewer (an undergraduate psychology student). Inter-rater reliability was calculated using 
Cohen’s Kappa. The value for Cohen’s Kappa was 0.78, p<0.01, suggesting a good level of 
inter-rater reliability. Articles considered relevant were retrieved in full text. These articles 
were then assessed for eligibility by both reviewers. Exclusions were reported, with reasons 
given. 
Data was extracted for the following study characteristics (by the undergraduate psychology 
student, verified by the first author): authors; date of publication; location; design; 
methodology; nature of the sample including sex and age; nature of disclosure recipient; and 
findings relating to HIV disclosure anxiety. 
Results 
After duplicates were removed, there were 426 articles. 159 articles were screened in as 
potentially eligible. 119 of these articles were subsequently considered eligible for the 
review. Most commonly articles were rejected as they did not report on anxiety about HIV 
disclosure.  
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Figure 1 summarises the review process. 
Figure 1 here 
Study characteristics are summarised in Table I. 
Table I here 
Study characteristics 
Fifty one of the studies took place in Africa, with a further 39 studies in North America. 
Fifteen studies took place in Asia, with 8 in Europe, 4 in South America and 2 in Australasia. 
There were three intervention studies17-19. The remainder of the studies were cross sectional.  
The most commonly used method to capture data was qualitative interviews (64 studies). 
Surveys were used in 43 studies, with focus groups in 18 studies. The other approaches used 
were self-report questionnaires (8 studies) and participant observations (3 studies). Fifteen of 
the studies used more than one method. 
Participants and disclosure recipients 
Sample sizes ranged from four to 775 (median sample size 52, IQR 26-164). Most commonly 
(59 studies), participants did not belong to a specific subgroup of HIV-positive individuals. 
Twenty three studies were based on parent samples. Other studies sampled ethnic minority 
groups (eight studies), individuals taking ART (six studies), adolescents (five studies), and 
MSM (three studies). The remainder (15 studies) sampled from diverse populations (e.g., 
intervention participants, sex workers and prisoners). Seventy seven of the studies sampled 
both males and females, 32 accessed female only samples, and ten studies sampled males 
only. The disclosure recipient was not specified in 77 of the studies. HIV disclosure to one’s 
partner was the focus of 24 studies. Other studies focused on disclosure to children (nine 
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studies), family and friends (five studies), work colleagues (three studies) and dentists (one 
study).  
Qualitative and survey findings 
The most commonly reported reason for non-disclosure or disclosure anxiety theme was the 
fear of discrimination or stigmatising responses from others (58 studies). Anxiety about 
rejection and abandonment (e.g., divorce from partner) was also reported frequently (54 
studies) with the specific fear of partner violence cited in 18 studies. Anxiety about 
secondary/indirect disclosure (disclosure recipients sharing one’s status with others) was 
commonly reported (17 studies), as was the concern about causing stress, worry and burden 
to others if they were disclosed to (15 studies). There were a range of other disclosure anxiety 
themes reported, including the fear of being blamed, worries about being isolated, anxiety 
about feeling guilty and ashamed, and concerns about losing one’s job. 
Anxiety about HIV disclosure was reported to be a barrier to ART initiation or adherence in 
14 studies, and to engagement in care for oneself or one’s child in eight studies. HIV 
disclosure anxiety was given as a reason for being isolated or lacking social support in five 
studies and was mentioned as a barrier to safer sex (e.g., condom use) in three studies.  
Quantitative findings 
A range of statistical associations with anxiety about HIV disclosure were reported in eight 
studies. Most commonly, associations with psychological variables were assessed. ‘HIV 
disclosure concerns’ was related to higher levels of general anxiety in two studies20,21. One 
study found a statistically significant relationship between ‘HIV disclosure concerns’ and 
depression21, but a different study failed to find this association20. The latter study also failed 
to find an association between ‘HIV disclosure concerns’ and life satisfaction but did find an 
association with reduced social support20. ‘HIV disclosure concerns’ were associated with 
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higher levels of HIV stigma in two studies21,22, and were associated with negative self-image, 
greater disengagement coping, less time since diagnosis, less primary control engagement and 
lower self-esteem in one study21.  
In relation to demographic and clinical variables, ‘HIV disclosure concerns’ was greater in 
females compared to males in one study23, and in heterosexual compared with 
homosexual/bisexual participants in three studies23-25. ‘HIV disclosure concerns’ were greater 
in individuals without an AIDS diagnosis in two studies24,25, and greater in those with lower 
CD4 counts, no HIV-related hospitalisations, no partner, and of younger age in one study25.  
Discussion 
The review suggests that anxiety about disclosing one’s HIV status is highly prevalent across 
region and population. Fears about rejection and discrimination from others appear 
ubiquitous.  More generally, anxiety seemed to focus on the possibility of negative effects for 
the individual living with HIV in the context of interpersonal relationships. There were also, 
however, frequently reported concerns about the effect on others of sharing one’s HIV status.  
There is some evidence from qualitative studies included in the review that negative 
consequences of anxiety about HIV disclosure, in terms of reduced ART adherence, poor 
engagement in care, and isolation, may occur. Importantly, participants themselves often 
cited fears about HIV disclosure as a reason for such negative outcomes. No quantitative 
studies examined these relationships.  
 
The review was limited by the fact that most of the studies were qualitative in nature. In 
addition, the few quantitative studies were cross sectional with only a limited range of 
correlates examined. Hence, it was not possible to quantify the extent to which HIV 
disclosure anxiety is related to other psychological and behavioural factors or to examine the 
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causes and consequences of HIV disclosure anxiety from the studies. Further, the majority of 
studies did not specify to whom the person living with HIV was disclosing. This is important 
as disclosure anxiety may differ depending on the recipient.  
Models of HIV disclosure  
There is a long tradition of developing models of HIV disclosure separate from models of the 
disclosure of other health conditions26. This may reflect specific issues associated with HIV 
(e.g., HIV stigma) and the fact that HIV disclosure may facilitate reductions in onward 
transmission. Given the likely importance of anxiety about disclosing one’s HIV status, it is 
surprising that explanatory models of HIV disclosure have rarely included anxiety as a 
central construct. A recent systematic review of HIV disclosure models27 found that 
individual cognitive determinants of HIV disclosure were commonly cited in models (e.g., 
self-efficacy and perceived disclosure risks and benefits), but affect, including anxiety, was 
not. Indeed, neither the presence of anxiety nor how it is develops and can be maintained has 
been included in HIV disclosure theories.  Not all disclosure decisions are likely to be 
influenced by anxiety but our systematic review suggestions that anxiety about HIV 
disclosure is common and may have important consequences. We suggest that high and 
persistent levels of anxiety about disclosure may have an impact on an individual’s quality of 
life and potentially their social and occupational functioning. 
A new theoretical model of HIV disclosure anxiety (rather than of disclosure behaviour) may 
help to direct clinicians towards interventions that help to support people with HIV with 
significant levels of anxiety and preoccupation about sharing their status with others. This 
may be particularly important where anxiety about HIV disclosure is having a large impact 
on the individual’s psychological and relational functioning and their engagement with care. 
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Aims of our model 
We present a new model of HIV disclosure anxiety that draws upon existing cognitive 
models of anxiety disorders to explain how high levels of anxiety about sharing one’s status 
with others develops and can be maintained. The approach of drawing on theoretical models 
relating to affect rather than of heath behaviour is novel in the HIV context. For example, the 
Health Belief Model28 was the most commonly used model used in a recent review of 
psychological correlates of HIV testing29, and the Information Motivation Behavioural Skills 
Model30 (based on the Theory of Planned Behaviour31) has guided much recent research on 
antiretroviral adherence. Such models primarily outline cognitive determinants of behaviour. 
It may be, however, that affect is another important determinant of many HIV-related 
behaviours. For example, consistent relationships between fear of HIV and HIV testing on 
the one hand and HIV testing itself on the other hand, have been reported29. It may also be 
that affect (particularly anxious affect) plays a key role in driving many HIV disclosure 
decisions. Of greater relevance for our model, however, is the possibility that high levels of 
anxiety about disclosure affects individuals’ quality of life and their social and occupational 
functioning (through processes such as avoidance leading to social isolation).  
Existing cognitive models of anxiety disorders emphasise cognitive and behavioural factors 
that maintain anxiety and minimise quality of life. Models of social anxiety32 are particularly 
relevant as HIV disclosure is a social phenomenon. Models of health anxiety33 are also 
relevant given the nature of the condition and the context of care and treatment. Such 
cognitive models attempt to integrate cognitive, affective and behavioural factors and have 
clear treatment implications. Existing cognitive models of anxiety disorders cannot be applied 
in their entirety, however. There are specific characteristics associated with HIV that require 
an HIV-specific model, including the extent of HIV stigma, and the infectious nature of the 
condition. In addition, models of social anxiety 32 have self-focused attention at their core, 
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whereas our systematic review suggests that it is the fear of the response of others which is 
central to HIV disclosure anxiety. Models of health anxiety 33 also suggest that self-directed 
interpretations (of symptoms) are key rather than interpersonal factors. 
Our model is designed to apply to individuals who have high levels of anxiety about HIV 
disclosure (e.g. a persistent fear of disclosure, with intense anxiety about one’s status being 
known) that has a significant impact on their functioning (e.g., significant interference with 
their normal routine, occupational/academic functioning, or social activities or relationships). 
This may be manifested in individuals being preoccupied with thoughts about not telling 
others that they are HIV-positive (direct disclosure), or about avoiding people finding out that 
they are HIV positive (indirect or guessed disclosure). The model is intended to apply to 
situations where the PLHIV fears their HIV-positive status will be shared (i.e., where they are 
motivated to avoid disclosure) or to situations where they want to or feel they have to 
disclose but are anxious about doing so (i.e., where to some extent the PLHIV is motivated to 
disclose). That is, anxiety is only likely to characterise situations where there is a level of 
motivation to either disclose or to avoid disclosure.  
Our model attempts to explain why some individuals are more affected by anxiety about 
sharing their status than others and why some situations are more anxiety-provoking than 
others, despite the ubiquitous nature of HIV disclosure anxiety. We argue, however, that 
levels of HIV disclosure anxiety are on a continuum both between people and within people 
(depending on the disclosure recipient and over time). At lower levels of anxiety about HIV 
disclosure, this may not interfere with decisions about sharing one’s status and may have a 
minimal impact on quality of life. The model aims to be consistent with existing evidence 
about HIV disclosure anxiety and HIV disclosure rates.  
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A model of HIV disclosure anxiety   
The model is outlined in Figure 2. 
Figure 2 here 
Evidence in relation to the model is presented in Table II.  
Table II here 
HIV core beliefs/HIV stigma and conditional assumptions 
We suggest that internalised HIV stigma34 (endorsing negative beliefs and feelings about HIV 
about oneself as an HIV-positive person) is a key distal determinant of HIV disclosure 
anxiety. Indeed, a relationship between HIV stigma and HIV disclosure concerns has been 
shown21,22, and there is evidence of an association between HIV stigma and reduced levels of 
HIV disclosure8,12. Feelings of shame, perhaps based on actual experiences of discrimination 
after previous disclosure12 (enacted stigma34) or difficulties in adjusting to an HIV-positive 
diagnosis, are argued to predispose individuals to HIV disclosure anxiety. Indeed, feelings of 
shame have been reported to inhibit HIV disclosure35, and conversely self-compassion has 
been associated with HIV disclosure36.  Negative beliefs about HIV (e.g., “People who are 
HIV-positive will have a short life expectancy”) are likely to contribute to internalised 
stigma. Illness beliefs are included as important determinants of health behaviour in many 
theoretical models13 and have shown to be related to depression in HIV-positive individuals 
37. There may be broader core beliefs about illness (e.g., “people who are ill are to blame”) 
and the self (e.g., “I am not a strong person”) that impact upon HIV core beliefs. 
Our model states that several contextual aspects are likely to influence the extent to which 
internalised HIV stigma is experienced and negative HIV core beliefs are endorsed. We use 
distinctions offered by Skovdal and colleagues38. Aspects of the symbolic context (e.g., 
community values, community HIV stigma, gender and sexuality representations) may 
impact upon internalised HIV stigma and HIV disclosure anxiety. Indeed, greater HIV 
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disclosure concerns been reported in women23, and heterosexual participants23-25. The 
material context may be relevant, consistent with evidence that greater disclosure fear is 
reported in those with no income39. Finally, the relational context is likely to influence 
internalised HIV stigma and HIV disclosure anxiety. For example, the HIV status of one’s 
partner and family members, their beliefs about HIV and HIV disclosure, and the quality of 
these relationships (e.g., the level of perceived trust), may influence internalised HIV stigma 
and HIV disclosure anxiety.  
Cognitive models of depression41 suggest that core beliefs produce conditional assumptions 
or rules that protect against distress and are activated in specific situations. For example, a 
belief that HIV is shameful may lead the individual to believe that they must hide their status 
from others to avoid being devastated by rejection (e.g., “If I hide my status, then I will be 
safe”).  Such rules for living can, however, be unhelpful if they form a barrier to personally 
important goals (e.g., accessing support).  Our model, therefore, includes the construct of 
conditional disclosure assumptions, arising from internalised HIV stigma. 
Trigger event 
We argue that HIV disclosure anxiety is heightened by specific events or situations which are 
interpreted in the light of negative core HIV beliefs and conditional assumptions about HIV 
disclosure. Indeed, our review suggested that HIV disclosure anxiety is present in particular 
contexts (e.g., taking ART medication in social situations, attending clinic, sexual situations) 
where HIV disclosure is thought to be required or wanted (direct disclosure), or where there 
might be a concern that one’s status will be revealed involuntarily or guessed (indirect or 
guessed disclosure). For example with the latter situation, individuals may be concerned that 
their antiretroviral use or their visits to clinic will be observed by others and that their status 
will, therefore, be inferred. An HIV diagnosis is likely to be an initial trigger to HIV 
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disclosure anxiety but subsequently episodes of disclosure anxiety may be prompted by 
different determinants.  
Within sexual relationships, a sense of responsibility to one’s partner and/or a concern about 
onward HIV transmission may trigger anxiety about disclosing, with a normative belief that 
one should share one’s status. This may occur in new relationships or when there is 
increasing depth within relationships.  Within friendships, a desire for closeness may trigger a 
perceived need to disclosure. Such situations may trigger disclosure approach goals (e.g., 
sharing one’s status to enhance relationship quality) or disclosure avoidance goals (e.g., 
hiding one’s status to avoid rejection and reduce potential relationship conflict)42.  
Threat interpretation and HIV disclosure anxiety 
A sense of threat (usually interpersonal in nature) is central to HIV disclosure anxiety. Our 
model uses a quasi-mathematical equation taken from a cognitive-behavioural model of 
health anxiety33 to describe this threat interpretation: the probability of a negative outcome 
multiplied by the awfulness of the outcome, divided by coping plus rescue factors.  
Greater anxiety will occur if the probability of negative outcomes (e.g., rejection from others) 
is predicted to be high. The greater the extent to which these outcomes are judged as awful, 
the more that anxiety is a likely outcome. Although these two synergistic components of 
perceived threat have not been separated in the HIV disclosure literature, it is likely that fears 
about discrimination/stigma, rejection, the effect on others and violence from studies 
included in the systematic review, are heightened by both perceptions of the likelihood and 
awfulness of the anticipated outcome. These perceptions may be experienced in the form of 
negative automatic thoughts or anxiety-laden images. Coping factors refer to the confidence 
in being able and prepared to face the anxiety of both sharing one’s HIV status and the 
outcome of HIV disclosure (and to cope with this anxiety). This may or may not be related to 
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one’s actual ability to manage anxiety in the feared situation or to disclose effectively. 
Perceived coping ability (related to the concept of self-efficacy) is likely to predict the extent 
to which an individual is motivated to face and persist in challenging situations related to 
status sharing. Rescue refers to the perceived ability of others to minimise the individual’s 
anxiety about disclosing and to provide helpful support.  
Previous disclosure experiences (and how these are appraised) are likely to influence all of 
the elements of the threat equation. Some theorists have, indeed, specified a role for previous 
disclosure experiences in making subsequent disclosure decisions42 and there is evidence that 
negative disclosure experiences inhibit future HIV disclosure12. One of the consequences of 
not sharing one’s HIV status is that there is no opportunity for the person living with HIV to 
learn that others' responses to HIV disclosure may be benign or supportive (or that they 
themselves can tolerate negative responses). As a result there may be an ongoing fear about 
disclosing, with less social support available if the individual chooses to share their status in 
the future12. 
Contextual factors will influence the extent to which the situation is perceived as threatening. 
Relational factors are argued to be particularly important. There is evidence that women 
living with HIV often disclose their status to family members first and then to partners, 
whereas men are more likely to disclose to partners first39.  There is also evidence that 
married individuals are more likely to disclose to partners, whereas non-married individuals 
tend to share their status with their family39. Finally, the quality of intimate relationships is 
associated with partner disclosure occurrence 40. These patterns of disclosure may signal 
differing levels of anxiety by characteristics of the discloser and their assessment of 
interpersonal threat associated with the disclosure recipient. Given the perceived threat 
associated with HIV disclosure, it is unsurprising that ambivalence about whether/when to 
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disclose is experienced. Indeed, one study reports the fear of abandonment weighing against 
the need for support and the desire to raise risk awareness in HIV disclosure decisions43.   
Maintaining factors  
Central to our model is the role of maintaining processes. It is these thoughts, feelings and 
behaviours that potentially maximise the negative impact of HIV disclosure anxiety and turn 
normative anxiety into something more problematic for the individual.  
Behavioural factors 
The most powerful anxiety maintenance process is avoidance of situations that provoke 
anxiety (situations where one’s status may be shared or inferred). The individual may, for 
example, avoid telling others about being HIV-positive and as a result may use condoms in 
sexual relationships rather than disclosing, only take medication when alone, and avoid 
sexual relationships completely to avoid sharing one’s status44. It is important to note that 
avoidance is a self-protective strategy that is helpful in the short term (as it reduces anxiety). 
Avoidance, however, reinforces threat interpretations as the individual fails to disconfirm 
anxious predictions and they remain alert to future threats33. We include avoidance in our 
model to signal situations where widespread avoidance of disclosure anxiety-provoking 
situations is part of a maintaining cycle that has a negative impact on individual functioning 
(given the effects of, for example, ongoing anxiety and reduced social support).  
Closely associated with avoidance is the use of safety seeking behaviours32. These are 
behaviours intended to prevent or minimise feared negative outcomes that may involve 
entering the feared situation but using subtle avoidance. Evidence from the systematic review 
includes reports of the hiding of bottle feeding and making excuses for bottle feeding45. Other 
examples of safety seeking behaviours might include only disclosing to other known HIV-
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positive people, attempting to assess the potential recipient’s HIV attitudes before deciding 
whether to disclose, or presenting a plausible alternative account for medication use12. Again, 
these strategies are not inherently unhelpful but they can become so if they play a part in a 
cycle that maintains perceived threat and this has a significant impact on functioning.  
Cognitive factors 
Cognitive factors maintaining disclosure anxiety may include preoccupation with thoughts 
about disclosing or others finding out about one’s HIV status, negative rumination and self-
focused attention in social situations where one’s HIV status is not known. There may be 
attentional biases, with a focus on attending to negative talk about people with HIV, as well 
as scanning for information about HIV and other people’s views about the condition. We 
suggest these factors based on the clinical anxiety literature32,33. They have not been 
investigated, to our knowledge, in HIV-positive populations. 
Affective and Physiological factors 
There is evidence that HIV disclosure concerns are positively associated with general levels 
of anxiety20,21. High levels of general anxiety are likely to maintain beliefs about 
interpersonal threat relating to specific disclosure situations. We also propose that HIV 
disclosure anxiety is characterised by increased arousal (e.g., sweating, feeling hot) in 
situations where disclosure of one’s status is possible or required. This aversive nature of 
these symptoms and the desire to use avoidance to manage them serves to maintain anxiety, 
similar to processes occurring in social anxiety32.  
Summary and conclusions 
We present a novel cognitive model of HIV disclosure anxiety that attempts to both explain 
the nature of high level of anxiety about sharing one’s HIV-positive status and to suggest 
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avenues for therapeutic intervention. Our model is the first HIV disclosure model that we are 
aware of to focus on the role of anxiety and factors that maintain HIV disclosure threat 
responses. The model is based on robust clinical models of anxiety disorders, adapted for the 
specific context of HIV disclosure. Our model differs from health anxiety models 33 in having 
the interpretation of future interpersonal situations at its core versus the interpretation of 
one’s own symptoms. It also highlights a specific role for (a) deeper level cognitions about 
the self in relation to the condition (e.g., internalised HIV stigma beliefs) (b) context, 
compared with health anxiety models. Our model differs from social anxiety models32 as it 
does not have self-focussed attention at its core, and instead highlights both a specific role for 
context, and provides more detail on the threat interpretation/feared prediction. 
 
There is evidence for some aspects of the model (e.g., the relationship between HIV stigma 
and HIV disclosure anxiety, and catastrophic beliefs concerning HIV disclosure outcome). 
Many components of the model, however, remain to be investigated (and there is an absence 
of standardised measures of HIV disclosure anxiety or its determinants that will facilitate 
model testing). For example, there have not been any attempts to separate out the different 
elements of threat interpretation to investigate whether the model accurately describes and 
predicts disclosure anxiety. Although there are not current measures of these beliefs, they 
could be operationalised and measured reliably and validly in the future.  Another limitation 
is that the model does not attempt to explain post-disclosure outcomes. Future research 
should attempt to operationalise key elements of the model (e.g., HIV disclosure anxiety, 
disclosure conditional assumptions, threat interpretations, and disclosure avoidance) so that 
relationships suggested by the model can be tested. In addition, the model would benefit from 
studies examining the prevalence of disclosure anxiety-related impact on quality of life and 
functioning in different HIV-positive populations. 
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Our model has clear clinical implications. In particular, we suggest that the existence of HIV 
disclosure anxiety should be normalised and the maintenance components of the model 
should be focused on in interventions where individuals are most affected by HIV disclosure 
anxiety and are motivated to consider sharing their status (threat interpretations, avoidance, 
safety-seeking behaviours, rumination, and attentional focus).  Many of the cognitive-
behavioural strategies used in treating health anxiety and social anxiety could be relevant for 
working with individuals who are most anxious about sharing their status. Such techniques 
could involve developing ways to challenge anxiogenic cognitions (e.g., cognitive 
restructuring and behavioural experiments), graded exposure to feared situations with the 
withdrawal of safety-seeking behaviours, teaching disclosure communication skills to 
enhance perceptions of coping, exploring different explanations for disclosure anxiety 
(Theory A versus Theory B), and accessing HIV disclosure support. In addition, motivational 
interviewing could be used to address disclosure ambivalence. The goals of such an 
intervention might be to help the individual to understand what maintains their high levels of 
anxiety, and to enable them to manage anxiety such that they can make a considered decision 
about how to respond to threat interpretations. This may help to break the HIV disclosure 
anxiety maintaining cycle, reducing both the preoccupation with HIV disclosure and 
disabling levels of anxiety. This may enable the sharing of one’s status in situations where 
the individual wants to disclose, or the management of anxiety in situations where one’s 
status is not known and there is no motivation to disclose. 
We argue that developing a new theory-based intervention to minimise significant levels of 
HIV disclosure anxiety, is warranted, given the limited evidence of existing effective 
interventions to reduce anxiety about HIV disclosure from the systematic review17-19.  It is 
interesting to note that the most promising of the interventions included in the review17 used 
some of the components that we suggest might be beneficial. 
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Figure 2: A Model of HIV Disclosure Anxiety 
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Table I: Disclosure anxiety studies 
Study Location Design (cross 
sectional unless 
stated)/ 
Methodology  
Sample (all HIV+) Disclosure 
recipient 
Findings related to HIV disclosure anxiety 
Akani & 
Erhabor (2006) 
Nigeria Survey 187 (82 females), 19-56 
years. 
Any  Fear of stigmatization, victimization, accusation of infidelity, and secondary disclosure 
cited as reasons for non-disclosure. 
Beauregard & 
Solomon (2005) 
Canada Qualitative 
interviews 
5 females, 40-48 years. Family Fear of disclosure due to stigmatization and uncertainty as to how people would react. 
Fear of being abandoned by family members, particularly children, due to lack of 
understanding. 
Bhagwanjee et al 
(2011) 
South Africa Qualitative 
interviews 
19 male mineworkers, 33-
57 years. 
Any Fear of being abandoned, causing stress or being treated differently cited as reasons for 
not disclosing to partners and family. Stigmatisation stated as reason for not disclosing to 
non-family.  
Bohle, Dilger & 
Groß (2014) 
Tanzania Participant 
observation, 
Survey. 
Qualitative 
interview 
59 females on ART (mean 
age 39 years). 
Any Fear of discrimination the main reason cited for non-disclosure. 
Brackis-Cott, 
Mellins & Block 
(2003) 
US Focus groups 12 HIV+ mothers, 30-48 
years, (mean 40 years). 
Children All HIV+ mothers had disclosed to their adolescent children, despite anxiety. 
Braitstein et al 
(2011) 
Kenya Survey Parents of 97 children lost 
to follow up (45% of who 
were known to be HIV+). 
43% female. Median age of 
child, 0.6 years. 
Any Most common reason given for not returning to the clinic was disclosure issues or fear of 
community or family discrimination (related to the mother’s own status or the child’s). 
 
  
Brickley et al 
(2009) 
Vietnam Qualitative 
interviews and 
focus groups 
Pregnant and postpartum 
females. 20 in interviews, 
14 in focus groups. 
19-34 years. 
Any Participants reported avoiding disclosure of their HIV status due to fear of stigma and 
discrimination, particularly in the wider community. 
Buchanan et al 
(2012) 
US Survey 120 perinatally infected 
children and adolescents 
(55 females), aged 8 to18 
Any Where the caregiver was fully responsible for adherence, there was significant agreement 
between caregiver and child on the reported barrier to ART adherence “child concerned 
that others notice medications” (k=0.41, p= .008). 
Table Click here to download Table Table I - Disclosure Anxiety Studies.docx 
years, mean age 12.8 years, 
and their parents/ 
caregivers. 
Busza et al 
(2013) 
Tanzania Qualitative 
interviews 
14 perinatally infected (5 
females), 15-19 years. 
Partners For those that acknowledged sexual feelings, concern about how to tell a potential partner 
about their status and how they might react. 
Bwirire et al 
(2008) 
Malawi Focus groups 10 antenatal and 6 
postnatal females and 9 
midwives, aged 20-55 
years. 
Partner (and 
community) 
Fear of stigma, discrimination, household conflict and divorce on disclosing were reasons 
cited for loss to follow up in a PMTCT programme. 
Catz et al (2012) US Qualitative 
interviews 
30 prisoners (9 females), 
20-58 years (mean 39 
years).  
Partners Fear of rejection cited as biggest deterrent to disclosing HIV status, and a barrier to risk 
reduction (e.g., condom use). 
Chakrapani et al 
(2010) 
India Survey, focus 
groups and 
qualitative 
interviews 
200 in survey (100 males, 
mean 34 years; 100 
females, mean 28.3 years); 
58 in focus groups, 
31 in Qualitative 
interviews. 
Partners Fear that disclosure will bring marital discord and family shame was a barrier to condom 
use. 
 
 
Chakrapani et al 
(2009) 
India Focus groups 19 female sex workers, 21-
48 years (mean 33 years). 
Any Fear of adverse consequences after disclosure, in particular, stigma and discrimination by 
family and community, was cited as a barrier to seeking ART. 
Chandra et al 
(2003) 
India Qualitative 
interviews 
68 (33 females), 18-50 
years (mean 31 years). 
Any (with 
emphasis on 
family) 
Reasons given for non-disclosure included fear of discrimination. 
Chin & Kroesen 
(1999) 
US Qualitative 
interviews 
9 Asian/Pacific Islander 
females, 21-51 years (mean 
38.8 years). 
Any Disclosure decisions influenced by fears of being stigmatized, concerns about 
disappointing or burdening others and concerns about discrimination. 
Christianson, 
Lolas & 
Johansson 
(2008) 
Sweden Qualitative 
interviews 
10 (5 females), 17-24 
years. 
Partners One participant reported that fear of disclosure led them to ‘switch off’ lust, leading to a 
lower sex drive so that the need to disclose was avoided. 
Cloete et al 
(2010) 
South Africa Focus groups 83- Males and Females 
aged 18+ 
(Demographic info not 
collected) 
Any Fear of disclosure due to concerns about rejection by family or partners, and loss of job.  
Colombini et al 
(2014) 
Kenya Qualitative 
interviews 
48 females (4 aged 18-24 
years, 32 aged 25-34 years, 
12 aged 35+ years). 
Any Fear of being discriminated against and being rejected cited as leading to non-disclosure, 
however this reportedly did not affect ART adherence and motivation to stay healthy. 
Conserve & 
King (2014) 
US Qualitative 
interviews 
21 (16 females), 18+ years, 
of Haitian decent. 
Any Barriers to disclosure included the fear of being stigmatized and rejected, and also 
concern that it may cause confidants (usually close family or friends) to worry. 
Corona et al 
(2006) 
US Survey 274 parents (216 female) 
mean age 35.8 years. 
Children Reasons for non disclosure- worry about emotional consequences of disclosure (67%) and 
worry that child would tell other people (28%). 
Curioso et al 
(2010) 
Peru Qualitative 
interviews 
31 on ART (3 females), 
18+ years. 
Any Fear of disclosure was a barrier to ART adherence: participants discussed having to be 
secretive with their medication. 
Dafarty & 
Padayatchi 
(2008) 
US Qualitative 
interviews 
40 with TB co-infection 
(24 females), 21-47 years 
(mean 34 years). 
Any Participants reported not adhering to ART due to fears of others seeing them taking the 
medication or going to collect it from the clinic.   
Dageid et al 
(2012) 
South Africa Qualitative 
interviews and 
focus groups 
23 males in interviews, 
aged 22-73 years (median 
39 years). 
8 males in focus group, 
aged  22-47 years (median 
32 years). 
Any Fear of rejection, isolation, tarnished reputations and perceived stigma given as reasons 
for non-disclosure. Five participants reported fearing violence following disclosure. 
Participants feared that loved ones may not be able to cope if they disclosed their HIV 
diagnosis to them. 
Degroote et al 
(2014) 
Belgium Survey 54 (4 females), 33-51 years 
(mean 42 years). 
Workplace Fear of social or professional consequences reported as a barrier to disclosure. 
Deribe et al 
(2008) 
Ethiopia Survey 705 (353 females) 166 
aged 18-25 years, 358 aged 
26-35 years, 181 aged >36 
years. 
Mainly 
partner. Also 
family, 
friends, 
church. 
Fear of partner reacting negatively cited as reason for non-disclosure (e.g., anger. 
Rejection/separation, violence, accusations of infidelity, worry) 
Deribe et al 
(2009/2010) 
Ethiopia Survey and 
Qualitative 
interviews 
706 (353 males, mean 34 
years; 353 females, mean 
29 years). 11 in-depth 
interviews (4 males, 7 
females). 
Partner  Anxiety about worrying partner and revealing unfaithfulness were reasons for non-
disclosure (men). Fear of violence, financial hardship, abandonment and being blamed 
cited as reasons for non-disclosure (women). 
Derlaga et al 
(2002/ 2004) 
US Survey 145 (39 females), Mean 
age 37 years. 
Any Perceived HIV-related stigma associated with reasons given for non-disclosure included 
fear of rejection. 
Diagne Gueye et 
al (2007) 
France Survey 54 mothers Mainly 
partner, also 
family, 
friends, 
church 
Fear of violence and separation were reasons for cited non-disclosure to partner. 
Dinkel (2014) Germany Self-report 
questionnaire 
167 MSM, 22-74 years 
(mean 45 years) 
  Any Disclosure concerns subscale of HIV Stigma Scale- associations with: HADS anxiety, r= 
0.19, p<0.05; HADS depression, r= 0.14, ns; Life Satisfaction (general), r= -0.1, ns; Life 
Satisfaction (health), r= 0.01, ns; Perceived Social Support, r= -0.17, p<0.05. 
Doherty et al 
(2006) 
South Africa Qualitative 
interviews 
40 mothers whom 
exclusively bottle/breast 
fed (mean 24 years). 
  Any Some participants reported hiding the fact that they bottle feed their baby as they feared 
others would find out/ think that it was because they are HIV+. Participants also reported 
making up other excuses to avoid stigma e.g., the baby would not breastfeed/ having other 
illnesses. 
Donahue et al 
(2012) 
Malawi Qualitative 
interviews 
59 females, 21-36 years. Any 
  
Fear of involuntary disclosure (and subsequent community stigmatisation) was a barrier 
to infant HIV testing and care programmes. 
Eisenhut et al 
(2009) 
UK Survey 62 mothers. Any A common reason given by mothers for not having their children tested was fear of 
disclosure to others (56%). 
Ekama et al 
(2012) 
Nigeria Survey 170 pregnant females                      
65 aged 18-29 years, 89 
aged 30–34 years,                                
16 aged ≥ 35 years.                          
Any Fear of being identified as HIV positive (63.6%) was the most common reason for 
nonadherence.  
 
Errol et al (2012) India Qualitative 
interviews  
13 interviewed (8 males, 3 
females, 2 transgender), 
aged 28-55 years. 
Any Participants reported fearing that neighbours or family would find out about their status or 
they would be forced to tell them due to home visits by staff from the HIV clinic. 
Ezechi et al 
(2009) 
Nigeria Survey 625 pregnant females. 
270 aged 18-29 years, 
322 aged 30-39 years, 
33 aged 40+ years. 
Partner Fear of rejection, stigma, and possible abuse were cited as reasons for non-disclosure. 
Fesko (2001) US Qualitative 
interviews 
18 (9 females), 2 aged 23-
30 years, 9 aged 31-40 
years, 7 aged 41-50 years. 
Workplace Fear of possible consequences such as being fired or rejected by co-workers were cited as 
reasons for non-disclosure. 
Fongkaew et al 
(2014) 
Thailand Qualitative 
interviews 
30 (13 females), 14-21 
years. 
Any Participants feared disclosure as they worried that they may be rejected by their partner or 
humiliated by their peer group due to stigmatisation and disgust; this reportedly led to 
non-adherence. 
Forsberg (1996) US Survey 306 with haemophilia co-
infection, mean 19 years). 
Partners Participants feared that their partner would not want to have sex with them after 
disclosure or that their partner may tell someone else about their status. 
Gari, Habte & 
Markos (2010) 
Ethiopia Survey 384 females attending ART 
clinics, 18-57 years (mean 
29.5 years). 
 Any Fear of abandonment, break-up and stigma reported as barriers to disclosure. 
Gaskins (2006) US Qualitative 
interviews 
20 African American 
males, 31-54 years. 
Any Concern about rejection and the disclosure recipients telling others were cited as barriers 
to disclosure. 
Gaskins et al 
(2011) 
US Qualitative 
interviews 
40 African American 
males, 22-49 years (mean 
38 years). 
Any Fear of negative reactions or stigma, and fear of the disclosure recipient telling others 
were common reasons reported for non-disclosure. 
Gielen et al 
(1997) 
US Qualitative 
interviews 
50 females, 16-45 years. Any Reasons quoted for non-disclosure included concerns about rejection, discrimination and 
violence. 
Gillard & Roark 
(2013) 
US Qualitative 
interviews and 
observations 
9 African American/ 
Hispanic ,17-19 years. 
Any Participants reported amotivation to disclose due to fear of stigma and negative 
reactions/consequences, particularly if previous confidants had reacted negatively, e.g., 
gossiping and rejection. 
Gorbach et al 
(2004) 
US Qualitative 
interviews 
55 MSM (mean 38.5 
years). 
Partners Some men reported a fear of being rejected by a prospective 
partner as a reason that they only disclosed sometimes. 
 
Gray (1999) US Survey 80 females, 20-65 years 
(mean 35.8 years). 
Any Fears related to disclosure and stigma reported more frequently than fears of dying. 
Greene et al 
(2013) 
US Intervention 
study  
 
Self-report 
questionnaire 
43 African American18 
males, 25 females, 20-64 
years (mean 47.3 years).  
 
 
Any Brief Disclosure Intervention (BDI). Disclosure anxiety measured by a single item asking 
participants to rate how anxious they feel before telling someone on a scale of 1-10. 
Participants also asked to describe how much they worry about telling others their status 
(rated from 0-5  by two coders reading the transcripts). 
 
Controlling for length of time since diagnosis, there was a condition by time interaction 
(F (1, 21)= 20.54, p<.001, partial η2= .49) with a decrease in disclosure anxiety in the 
intervention group from Time 1 pretest to delayed posttest (pretest M= 4.41, SD= .89; 
delayed posttest M=3.76, SD= 1.22). 
 
Controlling for length of time since diagnosis, there was a condition by time interaction 
(F(1, 40)= 3.70, p<.05, partial η2=.08) with a decrease in worry in the intervention group 
from pretest to immediate posttest (pretest M=3.68, SD=1.49; immediate posttest 
M=2.80, SD= 1.22) 
Grodensky et al 
(2015) 
US Qualitative 
interviews 
15 females, 50+ years 
(mean 57 years). 
Any Fear of disclosure cited as a barrier to making church connections and reportedly led to 
isolation. 
Hardon et al 
(2013) 
Burkino Faso, 
Kenya, Malawi 
& Uganda 
Survey  157 (90 female), mean 34.5 
years. 
Partners Fear of stigma, troubles being caused in the marriage and divorce cited as barriers to 
disclosure.  
Hays et al (1993)  US Survey 165 MSM, 24-68 years 
(mean 39.6 years). 
Any Fear of discrimination or disruptions of relationships were given as reasons for non-
disclosure. 
Hogwood, 
Campbell & 
Butler (2013) 
UK Qualitative 
interviews 
9 (7 females), 13-19 years 
(mean 16 years).  
Any Participants reported non-disclosure due to fear of rejection and isolation, and also a fear 
of losing control of the information due to others not maintaining secrecy. 
Holmes & Shea 
(1997) 
US Self-report 
questionnaire 
106 asymptomatic (28 
females), mean 37.8 years. 
Any  More disclosure worries (as measured by HAT QoL) in heterosexual versus homosexual / 
bisexual (p<0.05) and in females than males (p<0.05). 
Holmes & Shea 
(1998) 
US Self-report 
questionnaire 
201 (44 females), mean 
37.5 years. 
Any  More disclosure worries (as measured by HAT QoL) associated with higher CD4 count 
(p<0.05), non-AIDS diagnosis (versus AIDS)(p<0.01), no HIV-related hospitalization 
(p<0.01), younger age (p<0.05), heterosexual versus gay/bisexual (p<0.01), no partner 
versus partner (p<0.05). 
Holmes & Shea 
(1999) 
US Self-report 
questionnaire 
215 (42 females), mean 
37.8 years. 
Any More disclosure worries (as measured by HAT QoL) reported in heterosexuals and those 
with non-AIDS diagnosis (vs. AIDS), p<0.01. 
Hsuing & Tsai 
(2000) 
Taiwan Qualitative 
interviews 
14 males (mean 36 years). Any Fear of disclosure was a stressor. 
Issiaka et al 
(2001) 
Burkina Faso Survey 79 females, 18-38 years 
(mean 24.5 years). 
Partner Most frequently cited reasons for not disclosing to partner were fears of 
rejection/abandonment and fears of being considered unfaithful. 
Johnson (2012) Nigeria Survey 331 (164 females), 31 aged 
15-24 years, 150 aged 25-
34 years, 150 aged 35> 
years. 
Any Fear of stigmatization resulted in low disclosure outside immediate family (e.g., to 
colleagues or community). 
Kadowa & 
Nuwaha (2009) 
Uganda Survey  278 (197 females). 139 had 
not disclosed- Mean age 31 
years. 
Any  Fear of divorce or violence, discrimination or stigma, rumours/ gossip, and accusations of 
promiscuity/infidelity cited as reasons for non-disclosure. 
Kerrigan (2006) Brazil Qualitative 
interviews 
10 heterosexual females 
(mean 37 years), 10 
heterosexual males (mean 
38.5 years) and 10 MSM 
(Mean 40 years). 
Partners Women: fears related to disclosure were centred on the potential for negative partner 
reactions including rejection, abandonment and violence;  
 
Heterosexual men: fear of being labelled/ being treated differently;  
 
MSM: Fear of how partner would respond, risk of getting killed mentioned with casual 
partners. 
 
Kilewo et al 
(2001) 
Tanzania Survey 288 pregnant females, 18-
43 years (mean 27.7 years). 
Partner Fear of stigma, divorce and violence were reasons given for non-disclosure to partners. 
Klopper et al 
(2014) 
South Africa Survey 150 (106 females) Mean 36 
years. 
Any Fear of stigmatization, especially among males, cited as a major reason for delayed/non-
disclosure.  
 
Fear of stigmatization appeared to be associated with higher level of education. Fear of 
blame/discrimination appeared to be associated with less disclosure to sexual partner; 
more fear if no personal income and not married to partner. 
Kumar et al 
(2006) 
Barbados Qualitative 
Interviews 
139 females. 72 aged <25 
years, 67 >25 years. 
Any Fear of stigmatization by anyone, and fear of abnormal reaction and possible violence 
from partner cited as reasons for non-disclosure. 
Kyaddondo et al 
(2013) 
Uganda Focus groups 
and survey 
Focus groups – 16 parents 
(8 females). 
Survey - 148 parents (100 
females). 32 aged 18- 24 
years; 59 aged 25- 34 
years; 57 35+ years. 
Children  Reasons for non-disclosure to children include fear of being blamed/ judged as being 
sexually irresponsible, fears of rejection/isolation. 
Laryea & Gien 
(1993) 
Canada Qualitative 
interviews 
25 (6 females), 18-42 
years. 
Any Fears of rejection and discrimination were a barrier to disclosure. Fear of secret being 
shared, and the concern that this may prevent them from getting a job, particularly in 
small communities. 
Lee et al (2013) Thailand Focus groups 
and qualitative 
interviews 
Focus groups - 40; 
Interviews- 50 (35 female), 
mean age 37.5 years. 
Any Fear of rejection and disapproval, fear of breaches of privacy, perceived stigma and 
shame were barriers to disclosure. 
 
 
Liamputtong et 
al (2014) 
Thailand Qualitative 
interviews 
26 females. 4 20-30 years, 
17 31-40 years, 5 >40 
years. 
Family and 
children 
Non-disclosure due to fear of stigma, discrimination, blame and rejection. Worries about 
their partners’ well-being, as it would be assumed that they had HIV too. Concern that 
family members/children would not cope with disclosure. 
Lugalla et al Tanzania Qualitative 57 (27 females), most 20- Any Fear of being rejected and discriminated against were main reasons for non-disclosure in 
(2012) interviews 39 years. general. Both sexes reported finding it particularly difficult/ were very reluctant to 
disclose to their fathers. Women less likely to disclose to partners than men due to fear of 
violence and abandonment. 
Madiba & 
Canti-Sigaqa 
(2012) 
South Africa Focus groups 50 men aged 28-70 Any Several people reported that they did not want to attend support groups as they were 
afraid of exposing themselves and everyone knowing they were HIV+. 
One participant stated that the other participants in support groups are not trustworthy so 
he would not want to disclose his status there. 
Madiba (2013) South Africa Focus groups 26 parents (18 females), 
20-60 years. 
Children Fear of disclosure reported due to fear of onward disclosure from child, fear that the child 
is not mature enough to cope, and anticipated stigma and discrimination. 
Maiorana et al 
(2012) 
US Qualitative 
interviews 
52 who had participated in 
interventions purposively 
selected to represent 
clinics’ demographics.   
Any  Positive prevention interventions reported to help explore fears of stigma and rejection 
associated with disclosure. 
Maliska et al 
(2009) 
Brazil Qualitative 
interviews 
13 Family and 
friends 
Fear of disclosure associated with stigma. 
Maman et al 
(2001) 
Tanzania Qualitative 
interviews 
62- 26 female, 36 males. 
Mean age 28 years. (Only 
27 HIV+). 
Partners Women were more anxious about disclosing their positive test results than men, 
reportedly worrying about blame, abandonment and abuse. HIV+ men reported less 
disclosure anxiety, describing it as ‘like a normal conversation’. 
Maman et al 
(2003) 
Tanzania Survey 245 females, 3 months after 
testing. Mean age 32 years. 
(Only 73 HIV+). 
Partners Fear of partner’s reaction was the main reason cited for non-disclosure. Particular fear of 
abandonment and loss of economic support. 
Manopaiboon et 
al (1998) 
Thailand Survey 129 pregnant females,15-
37 years (median 22 years). 
Friends and 
family 
Non-disclosure associated with fear of disclosure outcome (e.g., family feeling ashamed). 
Mayanja et al 
(2013) 
Uganda Survey 421 pre-ART (271 
females). 318 > 30 years 
Any Fear of disclosure was most common worry before starting antiretroviral therapy. 
Mburu et al 
(2014) 
Zambia Qualitative 
interviews and 
focus groups 
Focus groups- 53; 
Interviews- 58 (29 
females), mean 16.8 years.  
Partners Fear of abandonment/ rejection (particularly by partners) and stigma were barriers to 
disclosure. 
Musumari 
(2013) 
DRC Qualitative 
interviews 
38 (24 females), median 
age 41 years. 
Any Fear of rejection and gossip cited as reasons for non-disclosure. Participants reported 
interrupting medication out of fear of disclosing status. 
Nagikosi et al Uganda Qualitative 48 refusing to engage in Any  Fear of stigma, rejection, blame, exclusion and devaluation were reported as most 
(2013) interviews HIV care. Aged 15-49 
years.  
common barriers to entering HIV care. Some also feared losing social support from 
caretakers if status was disclosed, or feared that it would prevent them from carrying out 
their own caring obligations for family. 
Nam et al (2009) Botswana Qualitative 
interviews 
21 parents (12 females), 
22-55 years (mean 37 
years). 
Children Concern that others may find out about their status and fear of children being stigmatized 
were reasons cited for non-disclosure. 
Newman et al 
(2007) 
Australia Qualitative 
interviews 
20 (16 females), 22-54 
years. 
Any Fear of disclosure and discrimination due to shame associated with HIV were major 
barriers to treatment uptake. 
Okoronkwo et al 
(2013) 
Nigeria Survey 221 attending ART clinic 
(126 females). 59 20-29 
years, 74 30-39 years, 55 
40-49 years. 
Any 188 admitted non-adherence. Fear of partner disclosure was a barrier to adherence in 
12.7% of females and 21% of males. 
Olagbuji et al 
(2011) 
Nigeria Survey 166 pregnant females on 
ART , 25-39 years (mean 
31.6 years) 
Partner Fear of spread of information, stigmatization and deterioration in relationships were most 
common reasons for non-disclosure. 
Osinde, Kakaire 
& Kaye (2012) 
Uganda Survey 403 (74% female, 83% on 
ART). 
27.1% 25-29 years. 
Partners Fear of stigma was main reason for non-disclosure. Some participants also reported 
fearing abuse, abandonment and rejection from partners if they disclosed to them. 
Paiva et al 
(2011) 
Brazil Qualitative 
interviews 
21 adolescents (10 female). 
13-20 years. 
Partners Fear of how their partner would react and fear of ending up alone were reasons cited for 
not disclosing HIV status to partner. 
Patel et al (2012) India Qualitative 
interviews 
30 (15 females), 15 aged 
20-30 years, 9 aged 31-40 
years, 6 aged 41-60 years. 
Any Fear of discrimination and fear of family breakdown were cited as barriers to disclosure.  
Petrak et al 
(2001) 
UK Survey 95 (79 males, mean 37.7 
years; 
16 females, mean  32.6 
years 
Any Most frequently cited reasons for non-disclosure included protecting themselves from 
others’ negative reactions, discrimination, stigma and concerns about confidentiality. 
Phaladze et al 
(2005) 
Botswana, 
Lesotho, South 
Africa, 
Swaziland 
Survey 743 (453 females) Mean 
age 34 years. 
Any Disclosure worries (as measured by the HAT-QoL) independently associated with 
reduced life satisfaction (p< .001). 
Pugatch et al US Semi-structured 6 (3 females). Aged 16-24 Family Fear of social stigma relating to HV disclosure was a barrier to ART adherence.  
(2002) interviews years. 
Rosen & 
Ketlapile (2010) 
South Africa Survey 260 lost to follow-up.  Any Fear of disclosure cited as a reason for loss to follow-up. 
Rothberg & Van 
Huyssteen (2008) 
South Africa Survey 28 (21 males,  mean 40.5 
years; 
7 females, mean 38.6 
years) 
Workplace Fear of disclosure of HIV status and stigmatisation were reasons cited for late registration 
onto a HIV treatment programme/ not using any support programmes. Participants also 
reported fear that employer will not maintain confidentiality. 
Rujumba et al 
(2012) 
Uganda Qualitative 
interviews 
15 pregnant females, 
aged18-43 years. 
Partners Non-disclosure due to fear of abandonment, violence and accusation of bringing HIV into 
the family. 
Schlebusch & 
Vawda (2010) 
South Africa Survey 112 who had attempted 
suicide (82 females, 30 
males), 18-48 years (mean 
34.9 years). 
Any 54% of participants reported fear of disclosure of their HIV status because of possible 
victimisation/stigmatisation. 
Seid, Wasie & 
Admassu (2012) 
Ethiopia Survey 360 (191 females), mean 
33.4 years. 
Partners Fear of divorce, stigma and discrimination, and physical abuse were main reasons given 
for non-disclosure. 
Sethosa & 
Peltzer (2005) 
South Africa Qualitative 
interviews 
55 (41 females) recently 
diagnosed (mean 27.9 
years). 
Any Reasons for non-disclosure included fear of negative reactions, discrimination, violence, 
and concerns about confidentiality. 
Siegel, Lekas & 
Schrimshaw 
(2005) 
 US Qualitative 
interviews 
158 females, mean 36 
years. 
Partners Both pre and post ART periods characterized by fears that disclosure would be met with 
rejection or a breach of confidentiality. 
Siu et al (2012) Uganda Focus groups 
and qualitative 
interviews 
20 (10 females),15-23 
years (Median 19 years) 
Any  Fear of secondary disclosure, discrimination, rejection and abuse cited as barriers to 
disclosure.  
Smith & Rapkin 
(1996) 
US Qualitative 
interviews 
224 (30 females). 73 aged 
24-35 years, 102 aged 36-
45 years, 
49 aged 46-56 years. 
Any Fear of disclosure of AIDS cited as a barrier to getting support from friends and family. 
Ssali et al (2010) Uganda Qualitative  
interviews 
40 (20 females). 10 of each 
sex > 35 years, 10 of each 
sex < 35 years old. 
 Any Fear of abandonment, particularly in young women disclosing to their partner, a common 
reason cited for non-disclosure. Fear of upsetting/worrying the disclosure recipient, 
particularly family members, given as another reason for non-disclosure. 
Stinson & Myer 
(2012) 
South Africa Survey 
 
28 females (17 pregnant, 
11 postpartum), mean 27 
years. 
Any Fear of disclosing HIV status was reported as a barrier for initiating ART during 
pregnancy. Fear of the confidant having a negative reaction (e.g., abandonment or 
stigmatisation). 
Stutterheim et al 
(2011) 
Netherlands Qualitative 
interviews 
42 of African and Afro-
Caribbean descent, aged 
18-70 years. 
Any Fear of stigmatization was most prevalent reason stated for non-disclosure. Sparing 
others, particularly parents and children, from worry another reason cited for non-
disclosure. 
Syed et al (2014) Malaysia Qualitative 
interviews 
13 (1 female), mean 34.4 
years. 
Any Main reason given for non-disclosure was that they did not want to hurt their family’s 
emotions. Fear of stigma and discrimination was also reportedly linked to non-disclosure. 
Terry, Jones & 
Brown (1994) 
New Zealand Survey 57 (4 females). 
12 aged 18-29 years, 21 
aged 30-39 years, 24 aged 
40-59 years. 
Dentist Reasons given by participants for not disclosing their HIV status to their dentist included 
fear of rejection, discrimination or breach of confidentiality.  
Teti et al (2010) US Survey, 
Qualitative 
interviews 
Survey (184 females) 
Qualitative (18 females), 
34- 51 years. 
Any  Fear of rejection and retaliation cited as reasons to be cautious about disclosing.  
Thanh, Moland 
& Fylkesnes 
(2010) 
Vietnam Qualitative 
interviews, 
focus groups, 
participant 
observation 
45 substance users (5 
females), 21-45 years.  
Any Fear of rejection and loss of intimacy reportedly made disclosure difficult and was said to 
be an obstacle to condom use in those recently diagnosed. 
Thomas, 
Nyamathi &  
Swaminathan 
(2009) 
India Focus groups 60 mothers, 23- 42 years 
(mean 30 years). 
Children Mothers reported that they feared disclosure may cause their children to discriminate 
against them, do badly in school, or tell others.  
Titilope et al 
(2011) 
Nigeria Uncontrolled 
intervention 
 
Survey 
499 (342 females), mean 
37.3 years. 
 
Partners Fear of rejection was most common reason for non-disclosure. Of those who had not yet 
disclosed their status, 30.7% reported that counselling had helped them overcome the fear 
of not wanting to disclose, but only 18.8% stated that they were willing to disclose. 
Tzemis et al 
(2013) 
Canada Self-report 
questionnaire 
775 on ART (25% 
females), 40-52 years 
(median 45 years). 
Any Disclosure concerns associated with HIV related stigma in both univariable and 
multivariable analysis (< .001). 
 
Unge et al (2008) Kenya Qualitative 
interviews 
26 (17 females), 23-55 
years. 
Any Fear of disclosure and its negative repercussions associated with not initiating ART. 
Vallerand et al 
(2005) 
US Qualitative 
interviews 
35 females, aged 27-56 
years (mean 38.5 years). 
Children Mothers expressed fears of rejection by their child or other potential negative reactions 
from their children if they disclosed to them. 
Van Devanter et 
al (2011) 
US Qualitative 
interviews 
26 Black and Latina 
females, 16-24 years 
Partners Fear of disclosure to new partners associated with risky sex (not using a condom). 
Van Nuil et al 
(2014) 
Rwanda Focus groups 42 on ART , aged 12-21 
years (median 17 years). 
Partner One of the most commonly reported HIV-related anxieties was how and when to disclose 
to a partner. 
Vance & 
Woodley (2005) 
US Qualitative 
interviews 
12 (2 females), 38-50 
years, (mean 44.4 years). 
Any Perceived barriers to successful ageing included fear of disclosure and stigma. 
Varni et al 
(2012) 
US Self-report 
questionnaire 
200 (72% male) aged 18-
64 years (Mean age 43.17 
years old). 
Any The disclosure concerns measure had a significant positive correlation with enacted 
stigma (r= .27, p≤ .01), concern with public attitudes (r= .47, p≤ .01), negative self-image 
(r= .46, p≤ .01), disengagement coping (r= .37, p≤ .01), depression (r= .24, p≤ .01), and 
anxiety (r= .21, p≤ .01). 
The disclosure concerns measure had a significant negative correlation with time (years) 
since diagnosis (r= -.14, p≤ .05), primary control engagement coping (r= -.26, ≤ .01), and 
self-esteem (r= -.18, p≤ .05). 
Visser et al 
(2008) 
South Africa Survey 293 recently diagnosed 
pregnant females (mean 
26.5 years). 
Any Fear of abandonment and discrimination weighed against need for support and desire to 
raise risk awareness in disclosure decisions. 
Walker (2012) US Qualitative 
interviews 
13 mothers.  Any Many women reported living in isolation and fearing disclosure. 
Ware, Wyatt & 
Tugenberg 
(2006) 
US Qualitative 
interviews 
52 (38 male, 14 female), 28 
30-40 years, 24 41-51 
years. 
Any Fear of disclosure was reported to result in missing medication as the interviewees did not 
want others to see them taking pills. 
Webel (2010) US Intervention 
 
Self-report 
questionnaire 
89 females (mean 47 
years). 
Any Peer based HIV symptom management intervention consisting of 7 two hour sessions, 
with the content of the sessions based on the Positive Self-Management Program (PSMP). 
The control group received a symptom management guide book.  
There was a significant difference found between groups for disclosure worries as 
measured by the HAT-QoL (χ2= 24.67, p<0.005). However, inspection of the means 
indicate that there was no significant group x time interaction. 
Wolf et al (2014) Kenya Qualitative 
interviews, 
focus groups 
27 (19 females), 15-21 
years. 
Adults Fear of status being disclosed to family reportedly affected medication adherence and 
caused loss-to-follow up. Also, youths’ dependent relationships with adults at home and 
school were reportedly negatively impacted by youths’ fear of disclosure caused by HIV-
related stigma. 
Zhou et al (2013) China Qualitative 
interviews 
39 parents (13 females), 
28-76 years (mean 42 
years).  
Children Fear of being stigmatized, fear of rejection, and fear of increased psychological burden to 
children were reasons for non-disclosure. 
Zukoski, 
Thorburn & 
Stroud (2011) 
US Qualitative 
interviews 
16 (7 female). 3 18-34 
years, 6 35-49 years, 7 50+ 
years. 
Any, 
particularly 
health profs. 
Fear of disclosure cited as a barrier to seeking information about HIV. 
 
Model component Sub-component Evidence 
HIV Core beliefs/HIV stigma 
 
 Higher levels of HIV stigma associated with higher levels of HIV disclosure 
concerns (Varni et al, 2012; Tzemis et al, 2013) and lower rates of HIV 
disclosure (Hult et al, 2012; various studies reported in Smith et al, 2008). 
Conditional assumptions  No evidence. 
Context  Greater disclosure concerns in women (Holmes & Shea, 1997) and heterosexual 
samples (Holmes & Shea, 1997, 1998, 1999). More disclosure fear in those with 
no income (Klopper et al, 2014). Different patterns of disclosure in males and 
females, and in marital and non-marital relationships (Klopper et al, 2014). More 
partner disclosure associated with better relationship quality (Seid et al, 2012). 
Trigger event  Various studies report anxiety about HIV disclosure in relation to ART initiation 
(e.g., Unge et al, 2008), ART adherence (e.g., Curioso et al, 2010), engagement 
in care (e.g., Nagikosi et al, 2013), and safer sex (Van Devanter et al, 2011).  
Threat interpretation  Many examples of perceived threat associated with HIV disclosure. No evidence 
of hypothesized components of threat interpretation.  
Maintaining factors Behavioural Hiding of bottle feeding (Doherty et al, 2006), only disclosing to other HIV+ 
people (Hult et al, 2012), using condoms instead of disclosing (Greenhalgh et al, 
2016), avoiding sexual relationships (Greenhalgh et al, 2016), missing ART 
doses (e.g., Dafarty & Padayatchi, 2008), not initiating ART (e.g., Unge et al, 
2008), not attending clinic (e.g., Braitstein et al, 2011), and avoiding the use of 
condoms (e.g., Catz et al, 2012). 
 Cognitive No evidence 
 Affective and 
Physiological 
HIV disclosure concerns associated with anxiety (Dinkel et al, 2014; Varni et al, 
2012).  
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